Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens

Background Diagnosis and treatment are central elements of strategies to control Trypanosoma brucei gambiense human African trypanosomiasis (HAT). Serological screening is a key entry point in diagnostic algorithms. The Card Agglutination Test for Trypanosomiasis (CATT) has been the most widely used screening test for decades, despite a number of practical limitations that were partially addressed by the introduction of rapid diagnostic tests (RDTs). However, current RDTs are manufactured using native antigens, which are challenging to produce. Methodology/Principal findings The objective of this study was to evaluate the accuracy of a new RDT developed using recombinant antigens (SD BIOLINE HAT 2.0), in comparison with an RDT produced using native antigens (SD BIOLINE HAT) and CATT. A total of 57,632 individuals were screened in the Democratic Republic of the Congo, either passively at 10 health centres, or actively by 5 mobile teams, and 260 HAT cases were confirmed by parasitology. The highest sensitivity was achieved with the SD BIOLINE HAT 2.0 (71.2%), followed by CATT (62.5%) and the SD BIOLINE HAT (59.0%). The most specific test was CATT (99.2%), while the specificity of the SD BIOLINE HAT and SD BIOLINE HAT 2.0 were 98.9% and 98.1%, respectively. Sensitivity of the tests was lower than previously reported, as they identified cases from partially overlapping sub-populations. All three tests were significantly more sensitive in passive than in active screening. Combining two or three tests resulted in a markedly increased sensitivity: When the SD BIOLINE HAT was combined with the SD BIOLINE HAT 2.0, sensitivity reached 98.4% in passive and 83.0% in active screening. Conclusions/Significance The recombinant antigen-based RDT was more sensitive than, and as specific as, the SD BIOLINE HAT. It was as sensitive as, but slightly less specific than CATT. While the practicality and cost-effectiveness of algorithms including several screening tests would need to be investigated, using two or more tests appears to enhance sensitivity of diagnostic algorithms, although some decrease in specificity is observed as well.

[1]  M. Humbert,et al.  A LiTat 1.5 variant surface glycoprotein‐derived peptide with diagnostic potential for Trypanosoma brucei gambiense , 2013, Tropical medicine & international health : TM & IH.

[2]  M. Humbert,et al.  Identification of Mimotopes with Diagnostic Potential for Trypanosoma brucei gambiense Variant Surface Glycoproteins Using Human Antibody Fractions , 2012, PLoS neglected tropical diseases.

[3]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[4]  C. Smales,et al.  Expression of Trypanosoma brucei gambiense Antigens in Leishmania tarentolae. Potential for Use in Rapid Serodiagnostic Tests (RDTs) , 2015, PLoS neglected tropical diseases.

[5]  J. R. Rosenblatt,et al.  W. J. Youden, 1900-1971 , 1972 .

[6]  Richard McCulloch,et al.  Evaluation of Antigens for Development of a Serological Test for Human African Trypanosomiasis , 2016, PloS one.

[7]  J. McConville,et al.  Rapid Diagnostic Test for Sleeping Sickness , 2013 .

[8]  M. Carrington,et al.  How Does the VSG Coat of Bloodstream Form African Trypanosomes Interact with External Proteins? , 2015, PLoS pathogens.

[9]  F. Chappuis,et al.  Options for Field Diagnosis of Human African Trypanosomiasis , 2005, Clinical Microbiology Reviews.

[10]  André Garcia,et al.  Untreated Human Infections by Trypanosoma brucei gambiense Are Not 100% Fatal , 2012, PLoS neglected tropical diseases.

[11]  M. A. Bray,et al.  Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies , 2014, Clinical Pharmacokinetics.

[12]  M. Gierliński,et al.  Evaluation of the Diagnostic Accuracy of Prototype Rapid Tests for Human African Trypanosomiasis , 2014, PLoS neglected tropical diseases.

[13]  Patrick T.K. Woo The haematocrit centrifuge technique for the diagnosis of African trypanosomiasis. , 1970, Acta tropica.

[14]  P. Simarro,et al.  Epidemiology of human African trypanosomiasis , 2014, Clinical epidemiology.

[15]  M. Boelaert,et al.  Human African Trypanosomiasis Diagnosis in First-Line Health Services of Endemic Countries, a Systematic Review , 2012, PLoS neglected tropical diseases.

[16]  W C Blackwelder,et al.  "Proving the null hypothesis" in clinical trials. , 1981, Controlled clinical trials.

[17]  Y. Guisez,et al.  Recombinant Antigens Expressed in Pichia pastoris for the Diagnosis of Sleeping Sickness Caused by Trypanosoma brucei gambiense , 2014, PLoS neglected tropical diseases.

[18]  P. Büscher,et al.  Rapid diagnostic test for sleeping sickness. , 2013, The New England journal of medicine.

[19]  P. Lutumba,et al.  Performance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo , 2017, PloS one.

[20]  V. Jamonneau,et al.  Improved Models of Mini Anion Exchange Centrifugation Technique (mAECT) and Modified Single Centrifugation (MSC) for Sleeping Sickness Diagnosis and Staging , 2009, PLoS neglected tropical diseases.

[21]  Marleen Boelaert,et al.  Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study , 2016, PLoS neglected tropical diseases.

[22]  Y. Guisez,et al.  Identification of Peptide Mimotopes of Trypanosoma brucei gambiense Variant Surface Glycoproteins , 2011, PLoS neglected tropical diseases.

[23]  Fabrizio Tediosi,et al.  Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review , 2015, Tropical medicine & international health : TM & IH.

[24]  G. Cross,et al.  The in vivo dynamics of antigenic variation in Trypanosoma brucei , 2015, Science.

[25]  M. Camara,et al.  Accuracy of Individual Rapid Tests for Serodiagnosis of Gambiense Sleeping Sickness in West Africa , 2015, PLoS neglected tropical diseases.

[26]  Mamadou Camara,et al.  Sleeping sickness diagnosis: use of buffy coats improves the sensitivity of the mini anion exchange centrifugation test , 2010, Tropical medicine & international health : TM & IH.

[27]  E. Fèvre,et al.  Estimating and Mapping the Population at Risk of Sleeping Sickness , 2012, PLoS neglected tropical diseases.

[28]  J. Menten,et al.  Performance of Parasitological and Molecular Techniques for the Diagnosis and Surveillance of Gambiense Sleeping Sickness , 2014, PLoS neglected tropical diseases.

[29]  Marleen Boelaert,et al.  Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study. , 2014, The Lancet. Global health.

[30]  M. Carrington,et al.  Proteomic Selection of Immunodiagnostic Antigens for Human African Trypanosomiasis and Generation of a Prototype Lateral Flow Immunodiagnostic Device , 2013, PLoS neglected tropical diseases.

[31]  P. Büscher,et al.  Review Article: Cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post‐treatment follow‐up , 2005, Tropical medicine & international health : TM & IH.

[32]  W. Gibson,et al.  Absence of the LiTat 1.3 (CATT antigen) gene in Trypanosoma brucei gambiense stocks from Cameroon. , 1992, Acta tropica.

[33]  P. Simarro,et al.  The journey towards elimination of gambiense human African trypanosomiasis: not far, nor easy , 2014, Parasitology.